DETERRING MISCONDUCT IN ACADEMIA* Halmar Halide Physics Dept FMIPA Unhas Validation, Reviewer and PAK pusat [email protected]* Workshop on Research Instrument and International Publication organized by Physics Study Program Held at Science Building FMIPA, Makassar, April 2 nd 2014 Halmar Halide @ physics unhas
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
* Workshop on Research Instrument and International Publication organized by Physics Study Program Held at Science Building FMIPA, Makassar, April 2nd 2014
Halmar Halide @ physics unhas
•Background: more retractions and irreproducible papers, cost of misconducts
• Misconducts (MCs): Plagiarism, Self-plagiarism, salami/tempe pub., bogus Authorship, COI
•Avoidance & Detectors: software
•Unhas efforts against MCs: Self-Assessment & Declarations
Halmar Halide @ physics unhas
Article withdrawal Policies and Formshttps://www.elsevier.com/about/publishing-guidelines/policies/article-withdrawal
Article Withdrawal: Only used for Articles in Press which represent early versions of articles and sometimes contain errors, or may have been accidentally submitted twice. Occasionally, but less frequently, the articles may represent infringements of professional ethical codes, such as multiple submission, bogus claims of authorship, plagiarism, fraudulent use of data or the like.
Article Retraction: Infringements of professional ethical codes, such as multiple submission, bogus claims of authorship, plagiarism, fraudulent use of data or the like. Occasionally a retraction will be used to correct errors in submission or publication.
Article Removal: Legal limitations upon the publisher, copyright holder or author(s).
Article Replacement: Identification of false or inaccurate data that, if acted upon, would pose a serious health risk.
…………the importance of the scholarly archive as a permanent, historic record of the transactions of scholarship. Articles that have been published shall remain extant, exact and unaltered as far as is possible. However, very occasionally circumstances may arise where an article is published that must later be retracted or even removed.
Unfortunately, Amgen's findings are consistent with those of others in industry. A team at Bayer HealthCare in Germany last year reported4 that only about 25% of published preclinical studies could be validated to the point at which projects could continue.
Fifty-three papers were deemed 'landmark' studiesNevertheless, scientific findings were confirmed in only 6 (11%) cases.
•Forging, altering, or falsifying documents•Using, obtaining or possessing unauthorized aids or assistance•Impersonating another person or having somone impersonate you•Plagiarism – representing as one’s own any idea or expression of an idea or work of another without proper citation•Submitting, without instructor’s knowledge or consent, work that has been previously submitted in another course/program•Submitting work containing concocted/false references•Continuing to write after a test/examination is over
•Plagiarizing•Collaboration/unauthorized assistance•Purchasing work•Recycling work - "double-dipping"•Resubmitting of altered work for re-grading•Electronic devices (cell phones) or any unauthorized aids•Altering medical certificates and UofT documents
Glenn Begley, former head of research at Amgen in Thousand Oaks, California, made headlines back in March when he revealed that scientists at his company had been unable to validate the conclusions of 47 out of 53 ‘landmark’ papers — papers exciting enough to inspire the possibilities of drug-discovery programmes. In one study, which has been cited over 1,900 times, not even the original researchers could reproduce the results in their own laboratory.
He listed six warning signs that a paper’s conclusions are unreliable: specimens were assessed without blinding, not all results were shown, experiments were not repeated, inappropriate statistical tests were used, reagents weren’t validated (polyclonal antibodies have limited uses) and positive and negative controls were not shown.
Flawed papers appear regularly in high-impact journals: “Once you start looking, it’s in every issue,” Begley said. Top-tier journals are publishing sloppy science, he continued.